| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. | Chief Medical & Development Officer | Stock Option (right to buy) | 425,000 | 22 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | 22 Jan 2025 | 1 | $0 | 4 | Chief Medical & Development Officer | 24 Jan 2025, 20:05 |
| KYTX | Kyverna Therapeutics, Inc. | 22 Jan 2025 | 0 | $0 | 3 | Chief Medical & Development Officer; Exhibit 24 - Power of Attorney | 24 Jan 2025, 20:00 |